| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 10 | +60.00% | +4.62% | +0.42% | +4.20% | -6.01% | — |
| 14d | 10 | +50.00% | -2.73% | +0.39% | -3.12% | -3.67% | — |
| 30d | 10 | +80.00% | -13.83% | +1.36% | -14.67% | -32.72% | — |
| 60d | 10 | +90.00% | -15.78% | +4.46% | -20.25% | -12.40% | — |
| 90d | 10(1 pending) | +88.89% | -27.04% | +7.85% | -37.63% | -34.55% | — |
| 180d | 10(2 pending) | +62.50% | -23.28% | +11.19% | -34.47% | -41.49% | — |
| 1y | 10(3 pending) | +71.43% | -32.75% | +19.71% | -52.46% | -72.62% | — |
| 2y | 10(5 pending) | +100.00% | -63.65% | +35.97% | -99.63% | -87.79% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KPTI KARYOPHARM THERAPEUTICS INC. | SALE EVP & Chief Medical Officer | 408 | $9.50 | $3.9K | 56,829 | May 14, 2026 | May 15, 2026 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 947 | — | — | 57,237 | May 13, 2026 | May 15, 2026 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | SALE EVP & Chief Medical Officer | 449 | $8.94 | $4.0K | 56,290 | Apr 21, 2026 | Apr 22, 2026 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | SALE EVP & Chief Medical Officer | 5,066 | $9.41 | $47.7K | 56,739 | Mar 2, 2026 | Mar 3, 2026 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 32,415 | — | — | 61,805 | Jan 31, 2026 | Feb 3, 2026 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | SALE EVP & Chief Medical Officer | 408 | $6.43 | $2.6K | 29,390 | Sep 15, 2025 | Sep 16, 2025 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 945 | — | — | 29,798 | Sep 12, 2025 | Sep 16, 2025 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | SALE EVP & Chief Medical Officer | 419 | $6.17 | $2.6K | 28,853 | Apr 23, 2025 | Apr 24, 2025 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | SALE EVP & Chief Medical Officer | 3,587 | $6.29 | $22.6K | 29,272 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 4,583 | — | — | 32,859 | Feb 28, 2025 | Mar 4, 2025 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 9,166 | — | — | 9,166 | Feb 28, 2025 | Mar 4, 2025 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 5,416 | — | — | 28,276 | Feb 28, 2025 | Mar 4, 2025 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 10,833 | — | — | 10,833 | Feb 28, 2025 | Mar 4, 2025 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | SALE EVP & Chief Medical Officer | 6,789 | $1.17 | $7.9K | 342,931 | Apr 22, 2024 | Apr 23, 2024 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | SALE EVP & Chief Medical Officer | 5,969 | $1.20 | $7.2K | 349,720 | Mar 1, 2024 | Mar 4, 2024 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | SALE EVP & Chief Medical Officer | 15,667 | $1.17 | $18.3K | 355,689 | Feb 29, 2024 | Mar 4, 2024 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 198,959 | — | — | 371,356 | Feb 28, 2024 | Feb 29, 2024 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 14,167 | — | — | 172,397 | Jan 24, 2024 | Jan 25, 2024 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | SALE10b5-1 10b5-1 plan | 115 | $4.03 | $463 | 164,885 | Apr 20, 2023 | Apr 24, 2023 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | SALE10b5-1 10b5-1 plan | 6,655 | $4.05 | $27.0K | 158,230 | Apr 20, 2023 | Apr 24, 2023 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 165,000 | Feb 28, 2023 | Mar 2, 2023 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Apr 29, 2022 | May 2, 2022 ↗ | View → |
| KPTI KARYOPHARM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 65,000 | — | — | 65,000 | Apr 29, 2022 | May 2, 2022 ↗ | View → |